The two-time Olympic gold medallist is among 36 per cent of people with the condition who are clinically diagnosed ...

Greenwich LifeSciences (GLSI) stock surges 23% premarket after promising Phase 3 results for GLSI-100, a breast cancer ...

It’s estimated that 1 in 100 people have it; however, only 36% with the condition are clinically diagnosed, according to Coeliac UK.

Immunotherapy has revolutionized the way physicians treat patients with cancer. This form of cancer treatment aims to direct the immune system toward the r | Immunology ...

Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically ...

Coeliac disease is an autoimmune condition where the body attacks ... Having certain gene markers, namely HLA-DQ2 or HLA-DQ8, can also increase your risk of developing the condition.

When Dr. Filippo Milano left his home in Italy to study medicine in Seattle in 2008, it was supposed to be for six months, ...

Sangamo Therapeutics, Inc.’s SGMO share price has dipped by 13.07%, which has investors questioning if this is right time to buy.